Diagnostics

November 25th 2024

Through AI technology, Neurophet AQUA now provides multiple sclerosis (MS) analysis with a combination of lesion quantification and enhanced segmentation of T2-FLAIR MRI.

April 17th 2024

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

November 28th 2023

Roche's Elecsys HBeAg quant is an immunoassay able to determine the presence and quantity of the hepatitis B e antigen in human serum and plasma.

November 14th 2023

PD-L1 IHC 22C3 pharmD approved to help identify patients who may be eligible to receive treatment with pembrolizumab (Keytruda) to treat gastric or gastroesophageal junction adenocarcinoma.